174 related articles for article (PubMed ID: 31793409)
1. New data on FII, FV, FIX and thrombomodulin defects: blood keeps clotting in normal and in peculiar ways.
Girolami A; Ferrari S; Girolami B; Randi ML
Hematology; 2019 Dec; 24(1):232-237. PubMed ID: 31793409
[No Abstract] [Full Text] [Related]
2. New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice.
Girolami A; Cosi E; Ferrari S; Lombardi AM; Girolami B
J Thromb Thrombolysis; 2017 Jul; 44(1):71-75. PubMed ID: 28251495
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX).
Girolami A; Ferrari S; Cosi E; Santarossa C; Randi ML
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):42S-47S. PubMed ID: 30428703
[TBL] [Abstract][Full Text] [Related]
4. Prothrombin: Another Clotting Factor After FV That Is Involved Both in Bleeding and Thrombosis.
Girolami A; Cosi E; Ferrari S; Girolami B
Clin Appl Thromb Hemost; 2018 Sep; 24(6):845-849. PubMed ID: 29690772
[TBL] [Abstract][Full Text] [Related]
5. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.
Dahlbäck B
Int J Lab Hematol; 2016 May; 38 Suppl 1():4-11. PubMed ID: 27161771
[TBL] [Abstract][Full Text] [Related]
6. Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed.
Girolami A; Ferrari S; Cosi E; Girolami B; Lombardi AM
Hematology; 2018 Mar; 23(2):105-110. PubMed ID: 28762299
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation.
Dargaud Y; Scoazec JY; Wielders SJ; Trzeciak C; Hackeng TM; Négrier C; Hemker HC; Lindhout T; Castoldi E
Blood; 2015 Feb; 125(9):1497-501. PubMed ID: 25564403
[TBL] [Abstract][Full Text] [Related]
8. Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation.
Girolami A; Cosi E; Ferrari S; Girolami B
J Thromb Thrombolysis; 2018 Jan; 45(1):135-141. PubMed ID: 29063359
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin-resistant prothrombin Yukuhashi mutation also causes thrombomodulin resistance in fibrinogen clotting but not in protein C activation.
Takagi Y; Kato I; Ando Y; Nakamura Y; Murata M; Takagi A; Murate T; Kojima T
Thromb Res; 2014 Oct; 134(4):914-7. PubMed ID: 25149909
[TBL] [Abstract][Full Text] [Related]
10. Factor V east Texas variant causes bleeding in a three-generation family.
Peterson JA; Gupta S; Martinez ND; Hardesty B; Maroney SA; Mast AE
J Thromb Haemost; 2022 Mar; 20(3):565-573. PubMed ID: 34847292
[TBL] [Abstract][Full Text] [Related]
11. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.
Margaglione M; Brancaccio V; De Lucia D; Martinelli I; Ciampa A; Grandone E; Di Minno G
Chest; 2000 Nov; 118(5):1405-11. PubMed ID: 11083693
[TBL] [Abstract][Full Text] [Related]
12. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
Dahlbäck B
Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
[TBL] [Abstract][Full Text] [Related]
13. Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Vandenbroucke JP
Arch Intern Med; 2000 Jan; 160(1):49-52. PubMed ID: 10632304
[TBL] [Abstract][Full Text] [Related]
14. Missense mutations in the gene encoding prothrombin corresponding to Arg596 cause antithrombin resistance and thrombomodulin resistance.
Takagi Y; Murata M; Kozuka T; Nakata Y; Hasebe R; Tamura S; Takagi A; Matsushita T; Saito H; Kojima T
Thromb Haemost; 2016 Nov; 116(6):1022-1031. PubMed ID: 27604259
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
Gemmati D; Serino ML; Moratelli S; Tognazzo S; Ongaro A; Scapoli GL
Haemostasis; 2001; 31(2):99-105. PubMed ID: 11684865
[TBL] [Abstract][Full Text] [Related]
16. Rare inherited coagulation and fibrinolytic defects that challenge diagnostic laboratories.
Mathews N; Tasneem S; Hayward CPM
Int J Lab Hematol; 2023 Jun; 45 Suppl 2():30-43. PubMed ID: 37211424
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis in rare bleeding disorders.
Ruiz-Sáez A
Hematology; 2012 Apr; 17 Suppl 1():S156-8. PubMed ID: 22507808
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
[TBL] [Abstract][Full Text] [Related]
19. Effect of five therapeutic strategies on the coagulation defect induced by the thrombomodulin c.1611C>A mutation.
Dargaud Y; Jourdy Y; Le Quellec S; Hemker CH; Lindhout T; Castoldi E; Negrier C
Br J Haematol; 2016 Sep; 174(6):993-6. PubMed ID: 26517807
[No Abstract] [Full Text] [Related]
20. Natural anticoagulants: A missing link in mild to moderate bleeding tendencies.
Mehic D; Colling M; Pabinger I; Gebhart J
Haemophilia; 2021 Sep; 27(5):701-709. PubMed ID: 34110661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
